Cargando…

The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response

Dengue is the most prevalent mosquito-borne viral disease worldwide. Yet, there are no vaccines or specific antivirals available to prevent or treat the disease. Several dengue vaccines are currently in clinical or preclinical stages. The most advanced vaccine is the chimeric tetravalent CYD-TDV vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flipse, Jacky, Smit, Jolanda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465930/ https://www.ncbi.nlm.nih.gov/pubmed/26065421 http://dx.doi.org/10.1371/journal.pntd.0003749

Ejemplares similares

Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses
por: Flipse, Jacky, et al.
Publicado: (2016)

How antibodies alter the cell entry pathway of dengue virus particles in macrophages
por: Ayala-Nunez, Nilda V., et al.
Publicado: (2016)

MicroRNA profiling of human primary macrophages exposed to dengue virus identifies miRNA-3614-5p as antiviral and regulator of ADAR1 expression
por: Diosa-Toro, Mayra, et al.
Publicado: (2017)

Human antibody response to dengue virus: implications for dengue vaccine design
por: Moi, Meng Ling, et al.
Publicado: (2016)

Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development
por: Tsai, Wen-Yang, et al.
Publicado: (2017)

The Human Antibody Response to Dengue Virus Infection
por: Wahala, Wahala M. P. B., et al.
Publicado: (2011)

Antibodies against Immature Virions Are Not a Discriminating Factor for Dengue Disease Severity
por: Rodenhuis-Zybert, Izabela A., et al.
Publicado: (2015)

A Review on Dengue Vaccine Development
por: Deng, Sheng-Qun, et al.
Publicado: (2020)

Complex interaction between dengue virus replication and expression of miRNA-133a
por: Castillo, Jorge Andrés, et al.
Publicado: (2016)

Human macrophages differentiated in the presence of vitamin D(3) restrict dengue virus infection and innate responses by downregulating mannose receptor expression
por: Arboleda Alzate, John F., et al.
Publicado: (2017)

Antibodies against the Envelope Glycoprotein Promote Infectivity of Immature Dengue Virus Serotype 2
por: da Silva Voorham, Júlia M., et al.
Publicado: (2012)

Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine
por: Tsuji, Isamu, et al.
Publicado: (2021)

T-cell Responses to Dengue Virus in Humans
por: Kurane, Ichiro, et al.
Publicado: (2011)

Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine
por: DeMaso, Christina R, et al.
Publicado: (2022)

Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development
por: Chokephaibulkit, Kulkanya, et al.
Publicado: (2020)

Dissecting the human serum antibody response to secondary dengue virus infections
por: Patel, Bhumi, et al.
Publicado: (2017)

Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement System
por: Nascimento, Eduardo J M, et al.
Publicado: (2022)

Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus
por: Ruiz Silva, Mariana, et al.
Publicado: (2017)

The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
por: Guzman, Maria G., et al.
Publicado: (2010)

A dengue vaccine whirlwind update
por: Kariyawasam, Ruwandi, et al.
Publicado: (2023)

Regulation of innate immune responses in macrophages differentiated in the presence of vitamin D and infected with dengue virus 2
por: Castillo, Jorge Andrés, et al.
Publicado: (2021)

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
por: Dussupt, Vincent, et al.
Publicado: (2020)

Current progress in dengue vaccines
por: Wan, Shu-Wen, et al.
Publicado: (2013)

Immature Dengue Virus: A Veiled Pathogen?
por: Rodenhuis-Zybert, Izabela A., et al.
Publicado: (2010)

Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art
por: Pintado Silva, Jessica, et al.
Publicado: (2023)

Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development
por: Roth, Claude, et al.
Publicado: (2018)

Efficacy of Tetravalent Dengue Vaccine: A Systematic Review and Meta-Analysis
por: Khobragade, Ashish Wasudeo, et al.
Publicado: (2021)

Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques
por: McCracken, Michael K., et al.
Publicado: (2021)

Preparedness for the Dengue Epidemic: Vaccine as a Viable Approach
por: Zeyaullah, Md., et al.
Publicado: (2022)

Vaccines and immunization strategies for dengue prevention
por: Liu, Yang, et al.
Publicado: (2016)

‘Mix and Match’ vaccination: Is dengue next?
por: Odio, Camila D., et al.
Publicado: (2022)

Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection
por: Xu, Meihui, et al.
Publicado: (2016)

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
por: Shukla, Rahul, et al.
Publicado: (2020)

Efficacy of Dengue Vaccines in the Prevention of Severe Dengue in Children: A Systematic Review
por: Foucambert, Paul, et al.
Publicado: (2022)

A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
por: Ambuel, Yuping, et al.
Publicado: (2014)

Antibody-dependent enhancement of severe dengue disease in humans
por: Katzelnick, Leah C., et al.
Publicado: (2017)

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
por: Brandler, Samantha, et al.
Publicado: (2007)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
por: Rajendran, Madhusudan, et al.
Publicado: (2021)

Systematic review of dengue vaccine efficacy
por: da Silveira, Lucia Teresa Côrtes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qve7jgcnrg0ug1vhhsaf74kmv8